IDH1 AND IDH2 GENE MUTATIONS IDENTIFY NOVEL MOLECULAR SUBSETS WITHIN DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML): A CANCER AND LEUKEMIA GROUP B (CALGB) STUDY

被引：0
|
作者：
Marcucci, G. [1 ]
Maharry, K. [1 ]
Wu, Y. Z. [1 ]
Radmacher, M. [1 ]
Mrozek, K. [1 ]
Margeson, D. [1 ]
Holland, K. [1 ]
Whitman, S. [1 ]
Becker, H. [1 ]
Schwind, S. [1 ]
Metzeler, K. [1 ]
Powell, B. [2 ]
Carter, T. [3 ]
Kolitz, J. [4 ]
Wetzler, M. [5 ]
Baer, M. [6 ]
Carroll, A. [7 ]
Caligiuri, M. [1 ]
Larson, R. [8 ]
Bloomfield, C. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA
[3] Univ Iowa, Iowa City, IA USA
[4] N Shore Univ Hosp, Manhasset, NY USA
[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[6] Univ Maryland, Baltimore, MD 21201 USA
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Chicago, Chicago, IL 60637 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1107
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [31] HIF1a Expression Is Associated with NPM1 Mutation, but Not IDH1 or IDH2 Mutations in Acute Myeloid Leukemia with Normal Karyotype
    Hu, S.
    Ruvolo, V.
    Lu, H.
    Kantarjian, H. M.
    Wheeler, D.
    Muzny, D. M.
    Medeiros, L. J.
    Bueso-Ramos, C.
    Konopleva, M.
    Andreeff, M.
    Konoplev, S.
    MODERN PATHOLOGY, 2012, 25 : 342A - 342A
  • [32] Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study
    Metzeler, Klaus H.
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Margeson, Dean
    Becker, Heiko
    Curfman, John
    Holland, Kelsi B.
    Schwind, Sebastian
    Whitman, Susan P.
    Wu, Yue-Zhong
    Blum, William
    Powell, Bayard L.
    Carter, Thomas H.
    Wetzler, Meir
    Moore, Joseph O.
    Kolitz, Jonathan E.
    Baer, Maria R.
    Carroll, Andrew J.
    Larson, Richard A.
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2010, 116 (21) : 48 - 49
  • [33] Rapid Screening of ASXL1, IDH1, IDH2, and c-CBL Mutations in de Novo Acute Myeloid Leukemia by High-Resolution Melting
    Ibanez, Mariam
    Such, Esperanza
    Cervera, Jose
    Luna, Irene
    Gomez-Segui, Ines
    Lopez-Pavia, Maria
    Dolz, Sandra
    Barragan, Eva
    Fuster, Oscar
    Llop, Marta
    Rodriguez-Veiga, Rebeca
    Avaria, Amparo
    Oltra, Silvestre
    Senent, M. Leonor
    Moscardo, Federico
    Montesinos, Pau
    Martinez-Cuadron, David
    Martin, Guillermo
    Sanz, Miguel A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 594 - 601
  • [34] IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
    Paschka, Peter
    Schlenk, Richard F.
    Gaidzik, Verena I.
    Habdank, Marianne
    Kroenke, Jan
    Bullinger, Lars
    Spaeth, Daniela
    Kayser, Sabine
    Zucknick, Manuela
    Goetze, Katharina
    Horst, Heinz-A.
    Germing, Ulrich
    Doehner, Hartmut
    Doehner, Konstanze
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3636 - 3643
  • [35] IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders
    Zou, Yang
    Zeng, Yun
    Zhang, Deng-Feng
    Zou, Shan-Hua
    Cheng, Yun-Feng
    Yao, Yong-Gang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 402 (02) : 378 - 383
  • [36] Gene and microRNA (miRNA) expression signatures and prognostic significance of CEBPA mutations in cytogenetically normal (CN) acute myeloid leukemia (AML)with high-risk molecular features:: A cancer and leukemia group B (CALGB) study
    Marcucci, Guido
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Vukosavljevic, Tamara
    Paschka, Peter
    Whitman, Susan P.
    Langer, Christian
    Baldus, Claudia D.
    Ruppert, Amy S.
    Powell, Bayard L.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2007, 110 (11) : 39A - 39A
  • [37] Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
    Sarkaria, S. M.
    Christopher, M. J.
    Klco, J. M.
    Ley, T. J.
    LEUKEMIA, 2014, 28 (12) : 2403 - 2406
  • [38] IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation
    Yamaguchi, Shunichiro
    Iwanaga, Eisaku
    Tokunaga, Kenji
    Nanri, Tomoko
    Shimomura, Taizo
    Suzushima, Hitoshi
    Mitsuya, Hiroaki
    Asou, Norio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 471 - 477
  • [39] Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)
    Whitman, Susan
    Kohlschmidt, Jessica
    Maharry, Kati
    Nicolet, Deedra
    Schwind, Sebastian
    Becker, Heiko
    Metzeler, Klaus H.
    Mrozek, Krzysztof
    Mendler, Jason H.
    Eisfeld, Ann-Kathrin
    Volinia, Stefano
    Powell, Bayard L.
    Carter, Thomas H.
    Kolitz, Jonathan E.
    Stone, Richard M.
    Park, Il-Kyoo
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2012, 120 (21)
  • [40] IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation
    Yamaguchi, Shunichiro
    Iwanaga, Eisaku
    Tokunaga, Kenji
    Nanri, Tomoko
    Shimomura, Taizo
    Suzushima, Hitoshi
    Okuno, Yutaka
    Mitsuya, Hiroaki
    Asou, Norio
    BLOOD, 2013, 122 (21)
12345